Sponsors

Rapid point-of-care diagnosis

bioMérieux is now supplying the QuickVue range of rapid diagnostic tests worldwide, as part of a long-term global alliance with Quidel for the development and distribution of rapid clinical diagnostic solutions.

Offering fast and cost-effective clinical solutions for point-of-care diagnostic testing, the QuickVue range of rapid diagnostics tests brings proven quality and reactivity to the detection of infectious diseases. The QuickVue range includes qualitative detection of influenza type A and type B antigens, a dipstick immunoassay for acute respiratory syncytial virus (RSV) infections and a one-step human chorionic gonadotrophin (hCG) test, as well as quick and simple tests for Helicobacter pylori, Chlamydia and group A streptococcal infections.

In addition, many new tests are in the development pipeline, combining Quidel’s rapid testing capabilities with bioMérieux’s expertise in immunochemistry and its extensive library of biologicals.
www.biomerieux.com

Latest Issues

Pathology Visions 24

Hyatt Regency, Orlando, FL
3-5 November, 2025

UK NEQAS Cellular Pathology Technique - Annual Participant’s Meeting

America Square Conference Centre, London, EC3N 2LB.
4 - 5 November, 2024

Medica

Messe Dusseldorf
11-14 November, 2024

POCT-for-Scot: Bringing the future to you

SEC Arena, Glasgow
14 November, 2024

Association for Molecular Pathology (AMP) 2024 Annual Meeting & Expo

Hyatt Regency, Vancouver, Canada
19-23 November, 2024